ID   SRBP1_MOUSE             Reviewed;        1134 AA.
AC   Q9WTN3; Q3U458; Q3UDJ3; Q5SRX5; Q8C733; Q99JK7;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   24-JUL-2007, sequence version 4.
DT   07-APR-2021, entry version 193.
DE   RecName: Full=Sterol regulatory element-binding protein 1 {ECO:0000303|PubMed:10052151, ECO:0000303|PubMed:9062340};
DE            Short=SREBP-1 {ECO:0000303|PubMed:10052151, ECO:0000303|PubMed:9062340};
DE   AltName: Full=Sterol regulatory element-binding transcription factor 1 {ECO:0000303|PubMed:10052151, ECO:0000303|PubMed:9062340};
DE   Contains:
DE     RecName: Full=Processed sterol regulatory element-binding protein 1 {ECO:0000305};
DE     AltName: Full=Transcription factor SREBF1 {ECO:0000305};
GN   Name=Srebf1 {ECO:0000312|MGI:MGI:107606};
GN   Synonyms=Srebp1 {ECO:0000303|PubMed:10052151, ECO:0000303|PubMed:9062340};
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM SREBP-1A).
RC   STRAIN=C57BL/6J, and NOD; TISSUE=Bone marrow, Kidney, and Thymus;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM SREBP-1A).
RC   STRAIN=C57BL/6J, and Czech II; TISSUE=Brain, and Mammary gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-41 (ISOFORMS SREBP-1A AND SREBP-1C), AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Liver;
RX   PubMed=9062340; DOI=10.1172/jci119247;
RA   Shimomura I., Shimano H., Horton J.D., Goldstein J.L., Brown M.S.;
RT   "Differential expression of exons 1a and 1c in mRNAs for sterol regulatory
RT   element binding protein-1 in human and mouse organs and cultured cells.";
RL   J. Clin. Invest. 99:838-845(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 42-444 (ISOFORMS SREBP-1A-W42 AND
RP   SREBP-1C-W42).
RX   PubMed=10052151; DOI=10.1271/bbb.63.243;
RA   Inoue J., Sato R.;
RT   "A novel splicing isoform of mouse sterol regulatory element-binding
RT   protein-1 (SREBP-1).";
RL   Biosci. Biotechnol. Biochem. 63:243-245(1999).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 55-1134.
RA   Lloyd D.J., Shackleton S., Trembath R.C.;
RT   "Mouse Srebp1.";
RL   Submitted (APR-2001) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   FUNCTION (ISOFORM SREBP-1A), AND SUBCELLULAR LOCATION.
RX   PubMed=8833906; DOI=10.1172/jci118951;
RA   Shimano H., Horton J.D., Hammer R.E., Shimomura I., Brown M.S.,
RA   Goldstein J.L.;
RT   "Overproduction of cholesterol and fatty acids causes massive liver
RT   enlargement in transgenic mice expressing truncated SREBP-1a.";
RL   J. Clin. Invest. 98:1575-1584(1996).
RN   [8]
RP   FUNCTION (ISOFORM SREBP-1C), AND SUBCELLULAR LOCATION.
RX   PubMed=9062341; DOI=10.1172/jci119248;
RA   Shimano H., Horton J.D., Shimomura I., Hammer R.E., Brown M.S.,
RA   Goldstein J.L.;
RT   "Isoform 1c of sterol regulatory element binding protein is less active
RT   than isoform 1a in livers of transgenic mice and in cultured cells.";
RL   J. Clin. Invest. 99:846-854(1997).
RN   [9]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=9329978; DOI=10.1172/jci119746;
RA   Shimano H., Shimomura I., Hammer R.E., Herz J., Goldstein J.L., Brown M.S.,
RA   Horton J.D.;
RT   "Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice
RT   homozygous for a targeted disruption of the SREBP-1 gene.";
RL   J. Clin. Invest. 100:2115-2124(1997).
RN   [10]
RP   FUNCTION.
RX   PubMed=9784493; DOI=10.1101/gad.12.20.3182;
RA   Shimomura I., Hammer R.E., Richardson J.A., Ikemoto S., Bashmakov Y.,
RA   Goldstein J.L., Brown M.S.;
RT   "Insulin resistance and diabetes mellitus in transgenic mice expressing
RT   nuclear SREBP-1c in adipose tissue: model for congenital generalized
RT   lipodystrophy.";
RL   Genes Dev. 12:3182-3194(1998).
RN   [11]
RP   INTERACTION WITH LMNA.
RX   PubMed=11929849; DOI=10.1093/hmg/11.7.769;
RA   Lloyd D.J., Trembath R.C., Shackleton S.;
RT   "A novel interaction between lamin A and SREBP1: implications for partial
RT   lipodystrophy and other laminopathies.";
RL   Hum. Mol. Genet. 11:769-777(2002).
RN   [12]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=11782483; DOI=10.1074/jbc.m111421200;
RA   Liang G., Yang J., Horton J.D., Hammer R.E., Goldstein J.L., Brown M.S.;
RT   "Diminished hepatic response to fasting/refeeding and liver X receptor
RT   agonists in mice with selective deficiency of sterol regulatory element-
RT   binding protein-1c.";
RL   J. Biol. Chem. 277:9520-9528(2002).
RN   [13]
RP   FUNCTION.
RX   PubMed=12855691; DOI=10.1074/jbc.m306540200;
RA   Horton J.D., Shimomura I., Ikemoto S., Bashmakov Y., Hammer R.E.;
RT   "Overexpression of sterol regulatory element-binding protein-1a in mouse
RT   adipose tissue produces adipocyte hypertrophy, increased fatty acid
RT   secretion, and fatty liver.";
RL   J. Biol. Chem. 278:36652-36660(2003).
RN   [14]
RP   FUNCTION.
RX   PubMed=16100574; DOI=10.1172/jci25614;
RA   Engelking L.J., Liang G., Hammer R.E., Takaishi K., Kuriyama H.,
RA   Evers B.M., Li W.P., Horton J.D., Goldstein J.L., Brown M.S.;
RT   "Schoenheimer effect explained--feedback regulation of cholesterol
RT   synthesis in mice mediated by Insig proteins.";
RL   J. Clin. Invest. 115:2489-2498(2005).
RN   [15]
RP   FUNCTION, AND INTERACTION WITH CEBPA.
RX   PubMed=17290224; DOI=10.1038/sj.emboj.7601563;
RA   Pedersen T.A., Bereshchenko O., Garcia-Silva S., Ermakova O., Kurz E.,
RA   Mandrup S., Porse B.T., Nerlov C.;
RT   "Distinct C/EBPalpha motifs regulate lipogenic and gluconeogenic gene
RT   expression in vivo.";
RL   EMBO J. 26:1081-1093(2007).
RN   [16]
RP   FUNCTION, PHOSPHORYLATION AT SER-331; SER-332 AND SER-395, AND MUTAGENESIS
RP   OF SER-331; SER-332 AND SER-395.
RX   PubMed=19244231; DOI=10.1074/jbc.m900096200;
RA   Yoon Y.S., Seo W.Y., Lee M.W., Kim S.T., Koo S.H.;
RT   "Salt-inducible kinase regulates hepatic lipogenesis by controlling SREBP-
RT   1c phosphorylation.";
RL   J. Biol. Chem. 284:10446-10452(2009).
RN   [17]
RP   INDUCTION.
RX   PubMed=19786558; DOI=10.1124/mol.109.057000;
RA   Cho Y., Noshiro M., Choi M., Morita K., Kawamoto T., Fujimoto K., Kato Y.,
RA   Makishima M.;
RT   "The basic helix-loop-helix proteins differentiated embryo chondrocyte
RT   (DEC) 1 and DEC2 function as corepressors of retinoid X receptors.";
RL   Mol. Pharmacol. 76:1360-1369(2009).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-448, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [19]
RP   FUNCTION, PHOSPHORYLATION AT SER-389, SUBCELLULAR LOCATION, AND MUTAGENESIS
RP   OF SER-354 AND SER-389.
RX   PubMed=21459323; DOI=10.1016/j.cmet.2011.03.009;
RA   Li Y., Xu S., Mihaylova M.M., Zheng B., Hou X., Jiang B., Park O., Luo Z.,
RA   Lefai E., Shyy J.Y., Gao B., Wierzbicki M., Verbeuren T.J., Shaw R.J.,
RA   Cohen R.A., Zang M.;
RT   "AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic
RT   steatosis and atherosclerosis in diet-induced insulin-resistant mice.";
RL   Cell Metab. 13:376-388(2011).
RN   [20]
RP   FUNCTION (ISOFORM SREBP-1A), TISSUE SPECIFICITY, AND DISRUPTION PHENOTYPE
RP   (ISOFORM SREBP-1A).
RX   PubMed=21531336; DOI=10.1016/j.cmet.2011.04.001;
RA   Im S.S., Yousef L., Blaschitz C., Liu J.Z., Edwards R.A., Young S.G.,
RA   Raffatellu M., Osborne T.F.;
RT   "Linking lipid metabolism to the innate immune response in macrophages
RT   through sterol regulatory element binding protein-1a.";
RL   Cell Metab. 13:540-549(2011).
RN   [21]
RP   INDUCTION BY ENDOCANNABINOID ANANDAMIDE.
RX   PubMed=21987372; DOI=10.1002/hep.24733;
RA   Jourdan T., Demizieux L., Gresti J., Djaouti L., Gaba L., Verges B.,
RA   Degrace P.;
RT   "Antagonism of peripheral hepatic cannabinoid receptor-1 improves liver
RT   lipid metabolism in mice: evidence from cultured explants.";
RL   Hepatology 55:790-799(2012).
RN   [22]
RP   REVIEW.
RX   PubMed=28849786; DOI=10.1038/nrendo.2017.91;
RA   Shimano H., Sato R.;
RT   "SREBP-regulated lipid metabolism: convergent physiology - divergent
RT   pathophysiology.";
RL   Nat. Rev. Endocrinol. 13:710-730(2017).
CC   -!- FUNCTION: [Sterol regulatory element-binding protein 1]: Precursor of
CC       the transcription factor form (Processed sterol regulatory element-
CC       binding protein 1), which is embedded in the endoplasmic reticulum
CC       membrane (PubMed:11782483, PubMed:12855691, PubMed:19244231). Low
CC       sterol concentrations promote processing of this form, releasing the
CC       transcription factor form that translocates into the nucleus and
CC       activates transcription of genes involved in cholesterol biosynthesis
CC       and lipid homeostasis (PubMed:11782483, PubMed:12855691,
CC       PubMed:16100574, PubMed:19244231). {ECO:0000269|PubMed:11782483,
CC       ECO:0000269|PubMed:12855691, ECO:0000269|PubMed:16100574,
CC       ECO:0000269|PubMed:19244231}.
CC   -!- FUNCTION: [Processed sterol regulatory element-binding protein 1]: Key
CC       transcription factor that regulates expression of genes involved in
CC       cholesterol biosynthesis and lipid homeostasis (PubMed:19244231,
CC       PubMed:17290224, PubMed:9329978, PubMed:9784493, PubMed:21459323).
CC       Binds to the sterol regulatory element 1 (SRE-1) (5'-ATCACCCCAC-3') (By
CC       similarity). Has dual sequence specificity binding to both an E-box
CC       motif (5'-ATCACGTGA-3') and to SRE-1 (5'-ATCACCCCAC-3') (By
CC       similarity). Regulates the promoters of genes involved in cholesterol
CC       biosynthesis and the LDL receptor (LDLR) pathway of sterol regulation
CC       (PubMed:19244231, PubMed:17290224, PubMed:9329978, PubMed:9784493,
CC       PubMed:21459323). {ECO:0000250|UniProtKB:P36956,
CC       ECO:0000269|PubMed:17290224, ECO:0000269|PubMed:19244231,
CC       ECO:0000269|PubMed:21459323, ECO:0000269|PubMed:9329978,
CC       ECO:0000269|PubMed:9784493}.
CC   -!- FUNCTION: [Isoform SREBP-1A]: Isoform expressed only in select tissues,
CC       which has higher transcriptional activity compared to SREBP-1C
CC       (PubMed:12855691, PubMed:21531336). Able to stimulate both lipogenic
CC       and cholesterogenic gene expression (PubMed:8833906). Has a role in the
CC       nutritional regulation of fatty acids and triglycerides in lipogenic
CC       organs such as the liver (PubMed:9062341, PubMed:12855691). Required
CC       for innate immune response in macrophages by regulating lipid
CC       metabolism (PubMed:21531336). {ECO:0000269|PubMed:12855691,
CC       ECO:0000269|PubMed:21531336, ECO:0000269|PubMed:8833906,
CC       ECO:0000269|PubMed:9062341}.
CC   -!- FUNCTION: [Isoform SREBP-1C]: Predominant isoform expressed in most
CC       tissues, which has weaker transcriptional activity compared to isoform
CC       SREBP-1A (PubMed:12855691, PubMed:21531336). Primarily controls
CC       expression of lipogenic gene (PubMed:8833906, PubMed:9062341). Strongly
CC       activates global lipid synthesis in rapidly growing cells
CC       (PubMed:8833906, PubMed:9062341). {ECO:0000269|PubMed:12855691,
CC       ECO:0000269|PubMed:21531336, ECO:0000269|PubMed:8833906,
CC       ECO:0000269|PubMed:9062341}.
CC   -!- SUBUNIT: [Sterol regulatory element-binding protein 1]: Forms a tight
CC       complex with SCAP, the SCAP-SREBP complex, in the endoplasmic reticulum
CC       membrane. {ECO:0000250|UniProtKB:P36956}.
CC   -!- SUBUNIT: [Processed sterol regulatory element-binding protein 1]:
CC       Efficient DNA binding of the soluble transcription factor fragment
CC       requires dimerization with another bHLH protein (By similarity).
CC       Interacts with CEBPA, the interaction produces a transcriptional
CC       synergy (PubMed:17290224). Interacts with LMNA (PubMed:11929849).
CC       {ECO:0000250|UniProtKB:P36956, ECO:0000269|PubMed:11929849,
CC       ECO:0000269|PubMed:17290224}.
CC   -!- INTERACTION:
CC       Q9WTN3; Q923E4: Sirt1; NbExp=2; IntAct=EBI-5273743, EBI-1802585;
CC   -!- SUBCELLULAR LOCATION: [Sterol regulatory element-binding protein 1]:
CC       Endoplasmic reticulum membrane {ECO:0000269|PubMed:21459323}; Multi-
CC       pass membrane protein {ECO:0000255}. Golgi apparatus membrane
CC       {ECO:0000269|PubMed:21459323}; Multi-pass membrane protein
CC       {ECO:0000255}. Cytoplasmic vesicle, COPII-coated vesicle membrane
CC       {ECO:0000269|PubMed:21459323}; Multi-pass membrane protein
CC       {ECO:0000255}. Note=At high sterol concentrations, the SCAP-SREBP is
CC       retained in the endoplasmic reticulum (PubMed:21459323). Low sterol
CC       concentrations promote recruitment into COPII-coated vesicles and
CC       transport of the SCAP-SREBP to the Golgi, where it is processed
CC       (PubMed:21459323). {ECO:0000269|PubMed:21459323}.
CC   -!- SUBCELLULAR LOCATION: [Processed sterol regulatory element-binding
CC       protein 1]: Nucleus {ECO:0000269|PubMed:21459323,
CC       ECO:0000269|PubMed:8833906, ECO:0000269|PubMed:9062341}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=SREBP-1A {ECO:0000303|PubMed:21531336,
CC       ECO:0000303|PubMed:8833906};
CC         IsoId=Q9WTN3-1; Sequence=Displayed;
CC       Name=SREBP-1A-W42;
CC         IsoId=Q9WTN3-2; Sequence=VSP_002152;
CC       Name=SREBP-1C {ECO:0000303|PubMed:9062341};
CC         IsoId=Q9WTN3-3; Sequence=VSP_002151;
CC       Name=SREBP-1C-W42;
CC         IsoId=Q9WTN3-4; Sequence=VSP_002151, VSP_002152;
CC   -!- TISSUE SPECIFICITY: [Isoform SREBP-1C]: Predominant isoform expressed
CC       in most tissues (PubMed:21531336). Predominates in liver, adrenal
CC       gland, brain and adipose tissue (PubMed:9062340). Also found in kidney,
CC       thymus, testis, muscle, jejunum, and ileum (PubMed:9062340).
CC       {ECO:0000269|PubMed:21531336, ECO:0000269|PubMed:9062340}.
CC   -!- TISSUE SPECIFICITY: [Isoform SREBP-1A]: Expressed only in select
CC       tissues, such as intestinal epithelial, heart, macrophage and bone
CC       marrow dendritic cells (PubMed:9062340, PubMed:21531336). Also found in
CC       kidney, thymus, testis, muscle, jejunum, and ileum (PubMed:9062340).
CC       {ECO:0000269|PubMed:21531336, ECO:0000269|PubMed:9062340}.
CC   -!- INDUCTION: [Isoform SREBP-1C]: Expressed in a circadian manner in the
CC       liver with a peak at ZT16 (PubMed:19786558).
CC       {ECO:0000269|PubMed:19786558}.
CC   -!- INDUCTION: Up-regulated by endocannabinoid anandamide/AEA.
CC       {ECO:0000269|PubMed:21987372}.
CC   -!- DOMAIN: The 9aaTAD motif is a transactivation domain present in a large
CC       number of yeast and animal transcription factors.
CC       {ECO:0000250|UniProtKB:P36956}.
CC   -!- PTM: [Sterol regulatory element-binding protein 1]: Processed in the
CC       Golgi apparatus, releasing the protein from the membrane. At low
CC       cholesterol the SCAP-SREBP complex is recruited into COPII vesicles for
CC       export from the endoplasmic reticulum. In the Golgi, complex SREBPs are
CC       cleaved sequentially by site-1 (MBTPS1, S1P) and site-2 (MBTPS2, S2P)
CC       proteases (By similarity). The first cleavage by site-1 protease occurs
CC       within the luminal loop, the second cleavage by site-2 protease occurs
CC       within the first transmembrane domain, releasing the transcription
CC       factor from the Golgi membrane (By similarity).
CC       {ECO:0000250|UniProtKB:P36956, ECO:0000250|UniProtKB:Q12772}.
CC   -!- PTM: Phosphorylated by AMPK, leading to suppress protein processing and
CC       nuclear translocation, and repress target gene expression.
CC       Phosphorylation at Ser-389 by SIK1 represses activity possibly by
CC       inhibiting DNA-binding. {ECO:0000269|PubMed:19244231,
CC       ECO:0000269|PubMed:21459323}.
CC   -!- PTM: [Processed sterol regulatory element-binding protein 1]:
CC       Ubiquitinated; the nuclear form has a rapid turnover and is rapidly
CC       ubiquitinated and degraded by the proteasome in the nucleus.
CC       {ECO:0000250|UniProtKB:P36956}.
CC   -!- DISRUPTION PHENOTYPE: Mice show high embryonic lethality around day 11
CC       dpc (PubMed:9329978). Surviving mice show a 2-3-fold increase in
CC       processed Srebpf2 protein in liver nuclei, 3-fold increase in
CC       cholesterol synthesis and 50% increase in cholesterol content of the
CC       liver (PubMed:9329978). {ECO:0000269|PubMed:9329978}.
CC   -!- DISRUPTION PHENOTYPE: [Isoform SREBP-1A]: Mice lacking isoform SREBP-1A
CC       are resistant to proinflammatory toxic shock (PubMed:21531336).
CC       Macrophages challenged with bacterial lipopolysaccharide fail to
CC       activate lipogenesis as well as hallmarks of inflammasome functions,
CC       activation of caspase-1 and secretion of IL1B (PubMed:21531336).
CC       {ECO:0000269|PubMed:21531336}.
CC   -!- DISRUPTION PHENOTYPE: [Isoform SREBP-1C]: Mice lacking isoform SREBP-1C
CC       show a lack of up-regulation of several lipogenic enzymes in response
CC       to high insulin or LXR activation. {ECO:0000269|PubMed:11782483}.
CC   -!- SIMILARITY: Belongs to the SREBP family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK052628; BAC35068.1; -; mRNA.
DR   EMBL; AK150052; BAE29268.1; -; mRNA.
DR   EMBL; AK154424; BAE32576.1; -; mRNA.
DR   EMBL; AK169607; BAE41256.1; -; mRNA.
DR   EMBL; AL669954; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC006051; AAH06051.1; -; mRNA.
DR   EMBL; BC056922; AAH56922.1; -; mRNA.
DR   EMBL; AB017337; BAA74795.1; -; mRNA.
DR   EMBL; AF374266; AAK54762.1; -; mRNA.
DR   CCDS; CCDS24785.1; -. [Q9WTN3-1]
DR   PIR; PD0035; PD0035.
DR   RefSeq; NP_001300908.1; NM_001313979.1.
DR   RefSeq; NP_035610.1; NM_011480.4. [Q9WTN3-1]
DR   RefSeq; XP_006532778.1; XM_006532715.2.
DR   SMR; Q9WTN3; -.
DR   BioGRID; 203495; 8.
DR   IntAct; Q9WTN3; 3.
DR   MINT; Q9WTN3; -.
DR   STRING; 10090.ENSMUSP00000020846; -.
DR   ChEMBL; CHEMBL3616359; -.
DR   iPTMnet; Q9WTN3; -.
DR   PhosphoSitePlus; Q9WTN3; -.
DR   PaxDb; Q9WTN3; -.
DR   PRIDE; Q9WTN3; -.
DR   ProteomicsDB; 254555; -. [Q9WTN3-1]
DR   ProteomicsDB; 254556; -. [Q9WTN3-2]
DR   ProteomicsDB; 254557; -. [Q9WTN3-3]
DR   ProteomicsDB; 254558; -. [Q9WTN3-4]
DR   Antibodypedia; 3952; 618 antibodies.
DR   Ensembl; ENSMUST00000020846; ENSMUSP00000020846; ENSMUSG00000020538. [Q9WTN3-1]
DR   GeneID; 20787; -.
DR   KEGG; mmu:20787; -.
DR   UCSC; uc007jfn.1; mouse. [Q9WTN3-1]
DR   CTD; 6720; -.
DR   MGI; MGI:107606; Srebf1.
DR   eggNOG; KOG2588; Eukaryota.
DR   GeneTree; ENSGT00940000159156; -.
DR   InParanoid; Q9WTN3; -.
DR   OrthoDB; 330300at2759; -.
DR   PhylomeDB; Q9WTN3; -.
DR   TreeFam; TF313894; -.
DR   Reactome; R-MMU-1655829; Regulation of cholesterol biosynthesis by SREBP (SREBF). [Q9WTN3-3]
DR   BioGRID-ORCS; 20787; 4 hits in 52 CRISPR screens.
DR   ChiTaRS; Srebf1; mouse.
DR   PRO; PR:Q9WTN3; -.
DR   Proteomes; UP000000589; Chromosome 11.
DR   RNAct; Q9WTN3; protein.
DR   Bgee; ENSMUSG00000020538; Expressed in liver and 116 other tissues.
DR   ExpressionAtlas; Q9WTN3; baseline and differential.
DR   Genevisible; Q9WTN3; MM.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:MGI.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; ISO:MGI.
DR   GO; GO:0016020; C:membrane; IDA:BHF-UCL.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; ISO:MGI.
DR   GO; GO:0003682; F:chromatin binding; IDA:MGI.
DR   GO; GO:0003677; F:DNA binding; IDA:UniProtKB.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; ISO:MGI.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; ISS:HGNC-UCL.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IDA:UniProtKB.
DR   GO; GO:0004879; F:nuclear receptor activity; ISO:MGI.
DR   GO; GO:0046983; F:protein dimerization activity; IEA:InterPro.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0044877; F:protein-containing complex binding; ISO:MGI.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IDA:MGI.
DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; ISO:MGI.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:MGI.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; ISO:MGI.
DR   GO; GO:0032810; F:sterol response element binding; ISS:HGNC-UCL.
DR   GO; GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IDA:MGI.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0071398; P:cellular response to fatty acid; IEA:Ensembl.
DR   GO; GO:0009267; P:cellular response to starvation; IDA:HGNC-UCL.
DR   GO; GO:0008203; P:cholesterol metabolic process; ISO:MGI.
DR   GO; GO:0007623; P:circadian rhythm; IEP:UniProtKB.
DR   GO; GO:0045444; P:fat cell differentiation; IMP:MGI.
DR   GO; GO:0008286; P:insulin receptor signaling pathway; IDA:MGI.
DR   GO; GO:0008610; P:lipid biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0010876; P:lipid localization; IEA:Ensembl.
DR   GO; GO:0030324; P:lung development; IEA:Ensembl.
DR   GO; GO:0042789; P:mRNA transcription by RNA polymerase II; IDA:MGI.
DR   GO; GO:0046676; P:negative regulation of insulin secretion; IMP:MGI.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:MGI.
DR   GO; GO:0045542; P:positive regulation of cholesterol biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0045723; P:positive regulation of fatty acid biosynthetic process; TAS:BHF-UCL.
DR   GO; GO:0031065; P:positive regulation of histone deacetylation; IDA:MGI.
DR   GO; GO:0045089; P:positive regulation of innate immune response; IMP:UniProtKB.
DR   GO; GO:0046889; P:positive regulation of lipid biosynthetic process; IMP:UniProtKB.
DR   GO; GO:1902895; P:positive regulation of pri-miRNA transcription by RNA polymerase II; IDA:BHF-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:MGI.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL.
DR   GO; GO:0010867; P:positive regulation of triglyceride biosynthetic process; IDA:UniProtKB.
DR   GO; GO:1903146; P:regulation of autophagy of mitochondrion; ISO:MGI.
DR   GO; GO:0019217; P:regulation of fatty acid metabolic process; IMP:MGI.
DR   GO; GO:0003062; P:regulation of heart rate by chemical signal; IMP:MGI.
DR   GO; GO:0050796; P:regulation of insulin secretion; IMP:MGI.
DR   GO; GO:0010883; P:regulation of lipid storage; IEA:Ensembl.
DR   GO; GO:0031647; P:regulation of protein stability; ISO:MGI.
DR   GO; GO:1903214; P:regulation of protein targeting to mitochondrion; ISO:MGI.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0051591; P:response to cAMP; IEA:Ensembl.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0045471; P:response to ethanol; IEA:Ensembl.
DR   GO; GO:0032094; P:response to food; IEA:Ensembl.
DR   GO; GO:0033762; P:response to glucagon; IEA:Ensembl.
DR   GO; GO:0009749; P:response to glucose; IMP:MGI.
DR   GO; GO:0032570; P:response to progesterone; IEA:Ensembl.
DR   GO; GO:0032526; P:response to retinoic acid; IEA:Ensembl.
DR   GO; GO:0032933; P:SREBP signaling pathway; ISS:UniProtKB.
DR   Gene3D; 4.10.280.10; -; 1.
DR   InterPro; IPR011598; bHLH_dom.
DR   InterPro; IPR036638; HLH_DNA-bd_sf.
DR   Pfam; PF00010; HLH; 1.
DR   SMART; SM00353; HLH; 1.
DR   SUPFAM; SSF47459; SSF47459; 1.
DR   PROSITE; PS50888; BHLH; 1.
PE   1: Evidence at protein level;
KW   Activator; Alternative splicing; Cholesterol metabolism;
KW   Cytoplasmic vesicle; DNA-binding; Endoplasmic reticulum; Golgi apparatus;
KW   Lipid metabolism; Membrane; Nucleus; Phosphoprotein; Reference proteome;
KW   Steroid metabolism; Sterol metabolism; Transcription;
KW   Transcription regulation; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   CHAIN           1..1134
FT                   /note="Sterol regulatory element-binding protein 1"
FT                   /id="PRO_0000127448"
FT   CHAIN           1..480
FT                   /note="Processed sterol regulatory element-binding protein
FT                   1"
FT                   /evidence="ECO:0000250|UniProtKB:Q12772"
FT                   /id="PRO_0000314030"
FT   TOPO_DOM        1..477
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        478..498
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        499..536
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        537..557
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        558..1134
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          317..367
FT                   /note="bHLH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00981"
FT   REGION          1..60
FT                   /note="Transcriptional activation (acidic)"
FT                   /evidence="ECO:0000250|UniProtKB:P36956"
FT   REGION          227..487
FT                   /note="Interaction with LMNA"
FT                   /evidence="ECO:0000269|PubMed:11929849"
FT   REGION          367..388
FT                   /note="Leucine-zipper"
FT   MOTIF           27..35
FT                   /note="9aaTAD"
FT                   /evidence="ECO:0000250|UniProtKB:P36956"
FT   COMPBIAS        61..175
FT                   /note="Pro/Ser-rich"
FT   COMPBIAS        420..453
FT                   /note="Gly/Pro/Ser-rich"
FT   SITE            451..452
FT                   /note="Cleavage; by caspase-3 and caspase-7"
FT                   /evidence="ECO:0000250|UniProtKB:Q12772"
FT   SITE            480..481
FT                   /note="Cleavage; by MBTPS2"
FT                   /evidence="ECO:0000250|UniProtKB:Q12772"
FT   SITE            519..520
FT                   /note="Cleavage; by MBTPS1"
FT                   /evidence="ECO:0000250|UniProtKB:P36956"
FT   MOD_RES         96
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P56720"
FT   MOD_RES         115
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P36956"
FT   MOD_RES         331
FT                   /note="Phosphoserine; by SIK1"
FT                   /evidence="ECO:0000269|PubMed:19244231"
FT   MOD_RES         332
FT                   /note="Phosphoserine; by SIK1"
FT                   /evidence="ECO:0000269|PubMed:19244231"
FT   MOD_RES         389
FT                   /note="Phosphoserine; by AMPK"
FT                   /evidence="ECO:0000269|PubMed:21459323"
FT   MOD_RES         395
FT                   /note="Phosphoserine; by SIK1"
FT                   /evidence="ECO:0000269|PubMed:19244231"
FT   MOD_RES         448
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         1047
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P36956"
FT   VAR_SEQ         1..29
FT                   /note="MDELAFGEAALEQTLAEMCELDTAVLNDI -> MDCTF (in isoform
FT                   SREBP-1C and isoform SREBP-1C-W42)"
FT                   /evidence="ECO:0000303|PubMed:10052151,
FT                   ECO:0000303|PubMed:9062340"
FT                   /id="VSP_002151"
FT   VAR_SEQ         90..131
FT                   /note="Missing (in isoform SREBP-1A-W42 and isoform SREBP-
FT                   1C-W42)"
FT                   /evidence="ECO:0000303|PubMed:10052151"
FT                   /id="VSP_002152"
FT   MUTAGEN         331
FT                   /note="S->A: Weakly affects phosphorylation by SIK1."
FT                   /evidence="ECO:0000269|PubMed:19244231"
FT   MUTAGEN         332
FT                   /note="S->A: Weakly affects phosphorylation by SIK1."
FT                   /evidence="ECO:0000269|PubMed:19244231"
FT   MUTAGEN         354
FT                   /note="S->A: Does not affect AMPK-mediated
FT                   phosphorylation."
FT                   /evidence="ECO:0000269|PubMed:21459323"
FT   MUTAGEN         389
FT                   /note="S->A: Abolishes AMPK-mediated phosphorylation."
FT                   /evidence="ECO:0000269|PubMed:21459323"
FT   MUTAGEN         395
FT                   /note="S->A: Strongly impairs affects phosphorylation by
FT                   SIK1."
FT                   /evidence="ECO:0000269|PubMed:19244231"
FT   CONFLICT        272..276
FT                   /note="Missing (in Ref. 1; BAE32576 and 6; AAK54762)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        795
FT                   /note="R -> P (in Ref. 1; BAE29268)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1003
FT                   /note="H -> N (in Ref. 3; AAH06051)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1061
FT                   /note="T -> A (in Ref. 3; AAH06051)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1134 AA;  120537 MW;  3D7422406E07A376 CRC64;
     MDELAFGEAA LEQTLAEMCE LDTAVLNDIE DMLQLINNQD SDFPGLFDAP YAGGETGDTG
     PSSPGANSPE SFSSASLASS LEAFLGGPKV TPAPLSPPPS APAALKMYPS VSPFSPGPGI
     KEEPVPLTIL QPAAPQPSPG TLLPPSFPAP PVQLSPAPVL GYSSLPSGFS GTLPGNTQQP
     PSSLPLAPAP GVLPTPALHT QVQSLASQQP LPASAAPRTN TVTSQVQQVP VVLQPHFIKA
     DSLLLTAVKT DAGATVKTAG ISTLAPGTAV QAGPLQTLVS GGTILATVPL VVDTDKLPIH
     RLAAGSKALG SAQSRGEKRT AHNAIEKRYR SSINDKIVEL KDLVVGTEAK LNKSAVLRKA
     IDYIRFLQHS NQKLKQENLT LRSAHKSKSL KDLVSACGSG GGTDVSMEGM KPEVVETLTP
     PPSDAGSPSQ SSPLSFGSRA SSSGGSDSEP DSPAFEDSQV KAQRLPSHSR GMLDRSRLAL
     CVLAFLCLTC NPLASLFGWG ILTPSDATGT HRSSGRSMLE AESRDGSNWT QWLLPPLVWL
     ANGLLVLACL ALLFVYGEPV TRPHSGPAVH FWRHRKQADL DLARGDFPQA AQQLWLALQA
     LGRPLPTSNL DLACSLLWNL IRHLLQRLWV GRWLAGQAGG LLRDRGLRKD ARASARDAAV
     VYHKLHQLHA MGKYTGGHLA ASNLALSALN LAECAGDAIS MATLAEIYVA AALRVKTSLP
     RALHFLTRFF LSSARQACLA QSGSVPLAMQ WLCHPVGHRF FVDGDWAVHG APPESLYSVA
     GNPVDPLAQV TRLFREHLLE RALNCIAQPS PGAADGDREF SDALGYLQLL NSCSDAAGAP
     ACSFSVSSSM AATTGPDPVA KWWASLTAVV IHWLRRDEEA AERLYPLVEH IPQVLQDTER
     PLPRAALYSF KAARALLDHR KVESSPASLA ICEKASGYLR DSLASTPTGS SIDKAMQLLL
     CDLLLVARTS LWQRQQSPAS VQVAHGTSNG PQASALELRG FQHDLSSLRR LAQSFRPAMR
     RVFLHEATAR LMAGASPART HQLLDRSLRR RAGSSGKGGT TAELEPRPTW REHTEALLLA
     SCYLPPAFLS APGQRMSMLA EAARTVEKLG DHRLLLDCQQ MLLRLGGGTT VTSS
//
